Meet with Pivotal bioVenture Partners

The global life sciences landscape is becoming increasingly interconnected, with China emerging as a major source of innovative assets and the United States and Europe providing established ecosystems for company building and global development. As companies pursue global growth, how can capabilities across these markets be brought together and what role can Singapore play?

Join JLABS Singapore for an exclusive session with Pivotal bioVenture Partners, the life sciences investment arm of Nan Fung Group, exploring how investors and biotech companies are navigating this evolving landscape. Drawing on perspectives from Pivotal and its portfolio companies, the session will examine the development of the US and China ecosystems, approaches to building globally-oriented companies around China-originated assets, and the practical considerations involved in cross-border operating models. The discussion will also consider what these models could mean for Singapore and how its ecosystem can support the growth of globally ambitious life sciences companies.